PART 2 – HIGH TIMES SOCAL MEDICAL CANNABIS CUP 2016

by | Feb 15, 2016 | Industry News | 0 comments

PART 2 – HIGH TIMES SOCAL MEDICAL CANNABIS CUP 2016

The Political Side of it all..

Well, HIGH TIMES SoCal Medical Cannabis Cup 2016, Part 2 of a two weekend event in San Bernardino, Ca. did not disappoint starting off Friday night with a concert by one of the most popular artist lobbying cannabis legalization, Mr. Wiz  Khalifa, On Saturday afternoon a good crowd also gathered to listen to a coalition of entrepreneurs, activists, environmentalists and state politicians discussing the current legislation and the how to and don’t, of the current Marijuana laws in California.

They also participated in the backing of physicians, and lobbyists of the California Medical Association, which announced that it is backing a proposed 2016 ballot initiative to legalize the recreational use of marijuana. An initiative, which is led by billionaire technology investor Sean Parker.

The California initiative would allow anyone age 21 or older to purchase up to an ounce of marijuana and grow up to six pot plants. An excise tax of 15 percent would be imposed on all non-medical sales.

California’s legislative analyst and finance director estimate that legalizing marijuana for recreational use could net as much as $1 billion in new tax revenue for the state and local governments. By the way, Initiative supporters have until July 5 to collect nearly 366,000 signatures to qualify for the November ballot. A dozen similar proposals have also been approved to collect signatures.

Wow! Just think, a visual, of an oasis of plants that would start to spruce out of control in the concrete jungles of Los Angeles, San Francisco, or just the thought of the many bud trimmers and compact cannabis trimming machines, to keep things in perspective. Yeah! Just think bud trimmers in almost every household! well again, just a thought.

~Michael Garay

Submit a Comment

Your email address will not be published. Required fields are marked *

GMP refers to the Good Manufacturing Practice Regulations promulgated by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act (See Chapter IV for food, and Chapter V, Subchapters A, B, C, D, and E for drugs and devices.) These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take proactive steps to ensure that their products are safe, pure, and effective. GMP regulations require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mixups, and errors. This in turn, protects the consumer from purchasing a product which is not effective or even dangerous. Failure of firms to comply with GMP regulations can result in very serious consequences including recall, seizure, fines, and jail time.

GMP regulations address issues including record keeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. Most GMP requirements are very general and open-ended, allowing each manufacturer to decide individually how to best implement the necessary controls. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner which makes sense for each individual business.

GMP is also sometimes referred to as “cGMP”. The “c” stands for “current,” reminding manufacturers that they must employ technologies and systems which are up-to-date in order to comply with the regulation.